439 related articles for article (PubMed ID: 19036965)
41. Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease.
Slow EJ; van Raamsdonk J; Rogers D; Coleman SH; Graham RK; Deng Y; Oh R; Bissada N; Hossain SM; Yang YZ; Li XJ; Simpson EM; Gutekunst CA; Leavitt BR; Hayden MR
Hum Mol Genet; 2003 Jul; 12(13):1555-67. PubMed ID: 12812983
[TBL] [Abstract][Full Text] [Related]
42. Mutant huntingtin's effects on striatal gene expression in mice recapitulate changes observed in human Huntington's disease brain and do not differ with mutant huntingtin length or wild-type huntingtin dosage.
Kuhn A; Goldstein DR; Hodges A; Strand AD; Sengstag T; Kooperberg C; Becanovic K; Pouladi MA; Sathasivam K; Cha JH; Hannan AJ; Hayden MR; Leavitt BR; Dunnett SB; Ferrante RJ; Albin R; Shelbourne P; Delorenzi M; Augood SJ; Faull RL; Olson JM; Bates GP; Jones L; Luthi-Carter R
Hum Mol Genet; 2007 Aug; 16(15):1845-61. PubMed ID: 17519223
[TBL] [Abstract][Full Text] [Related]
43. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice.
Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC
PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194
[TBL] [Abstract][Full Text] [Related]
44. Protective up-regulation of CK2 by mutant huntingtin in cells co-expressing NMDA receptors.
Fan MM; Zhang H; Hayden MR; Pelech SL; Raymond LA
J Neurochem; 2008 Feb; 104(3):790-805. PubMed ID: 17971125
[TBL] [Abstract][Full Text] [Related]
45. C57BL/6 Background Attenuates mHTT Toxicity in the Striatum of YAC128 Mice.
Back MK; Kurzawa J; Ruggieri S; von Engelhardt J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884469
[TBL] [Abstract][Full Text] [Related]
46. PGC-1α negatively regulates extrasynaptic NMDAR activity and excitotoxicity.
Puddifoot C; Martel MA; Soriano FX; Camacho A; Vidal-Puig A; Wyllie DJ; Hardingham GE
J Neurosci; 2012 May; 32(20):6995-7000. PubMed ID: 22593067
[TBL] [Abstract][Full Text] [Related]
47. Selective degeneration in YAC mouse models of Huntington disease.
Van Raamsdonk JM; Warby SC; Hayden MR
Brain Res Bull; 2007 Apr; 72(2-3):124-31. PubMed ID: 17352936
[TBL] [Abstract][Full Text] [Related]
48. Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease.
Graham RK; Pouladi MA; Joshi P; Lu G; Deng Y; Wu NP; Figueroa BE; Metzler M; André VM; Slow EJ; Raymond L; Friedlander R; Levine MS; Leavitt BR; Hayden MR
J Neurosci; 2009 Feb; 29(7):2193-204. PubMed ID: 19228972
[TBL] [Abstract][Full Text] [Related]
49. Alterations in striatal synaptic transmission are consistent across genetic mouse models of Huntington's disease.
Cummings DM; Cepeda C; Levine MS
ASN Neuro; 2010 Jun; 2(3):e00036. PubMed ID: 20585470
[TBL] [Abstract][Full Text] [Related]
50. Decreasing Levels of the cdk5 Activators, p25 and p35, Reduces Excitotoxicity in Striatal Neurons.
Park KH; Lu G; Fan J; Raymond LA; Leavitt BR
J Huntingtons Dis; 2012; 1(1):89-96. PubMed ID: 24353748
[TBL] [Abstract][Full Text] [Related]
51. Caspase-6-Resistant Mutant Huntingtin Does not Rescue the Toxic Effects of Caspase-Cleavable Mutant Huntingtin in vivo.
Graham RK; Deng Y; Pouladi MA; Vaid K; Ehrnhoefer D; Southwell AL; Bissada N; Franciosi S; Hayden MR
J Huntingtons Dis; 2012; 1(2):243-60. PubMed ID: 25063333
[TBL] [Abstract][Full Text] [Related]
52. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
[TBL] [Abstract][Full Text] [Related]
53. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease?
Kennedy L; Shelbourne PF
Hum Mol Genet; 2000 Oct; 9(17):2539-44. PubMed ID: 11030759
[TBL] [Abstract][Full Text] [Related]
54. Age-dependent changes in the calcium sensitivity of striatal mitochondria in mouse models of Huntington's Disease.
Brustovetsky N; LaFrance R; Purl KJ; Brustovetsky T; Keene CD; Low WC; Dubinsky JM
J Neurochem; 2005 Jun; 93(6):1361-70. PubMed ID: 15935052
[TBL] [Abstract][Full Text] [Related]
55. Huntington disease: new insights on the role of huntingtin cleavage.
Wellington CL; Leavitt BR; Hayden MR
J Neural Transm Suppl; 2000; (58):1-17. PubMed ID: 11128600
[TBL] [Abstract][Full Text] [Related]
56. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration.
Hodgson JG; Agopyan N; Gutekunst CA; Leavitt BR; LePiane F; Singaraja R; Smith DJ; Bissada N; McCutcheon K; Nasir J; Jamot L; Li XJ; Stevens ME; Rosemond E; Roder JC; Phillips AG; Rubin EM; Hersch SM; Hayden MR
Neuron; 1999 May; 23(1):181-92. PubMed ID: 10402204
[TBL] [Abstract][Full Text] [Related]
57. Forebrain striatal-specific expression of mutant huntingtin protein in vivo induces cell-autonomous age-dependent alterations in sensitivity to excitotoxicity and mitochondrial function.
Kim SH; Thomas CA; André VM; Cummings DM; Cepeda C; Levine MS; Ehrlich ME
ASN Neuro; 2011 Jun; 3(3):e00060. PubMed ID: 21542802
[TBL] [Abstract][Full Text] [Related]
58. Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice.
Naydenov AV; Sepers MD; Swinney K; Raymond LA; Palmiter RD; Stella N
Neurobiol Dis; 2014 Nov; 71():140-50. PubMed ID: 25134728
[TBL] [Abstract][Full Text] [Related]
59. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.
Menalled LB; Sison JD; Wu Y; Olivieri M; Li XJ; Li H; Zeitlin S; Chesselet MF
J Neurosci; 2002 Sep; 22(18):8266-76. PubMed ID: 12223581
[TBL] [Abstract][Full Text] [Related]
60. The sigma-1 receptor mediates the beneficial effects of pridopidine in a mouse model of Huntington disease.
Ryskamp D; Wu J; Geva M; Kusko R; Grossman I; Hayden M; Bezprozvanny I
Neurobiol Dis; 2017 Jan; 97(Pt A):46-59. PubMed ID: 27818324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
